novel
coronaviru
cov
describ
associ
case
sever
acut
respiratori
syndrom
sar
viru
sarscov
differ
previous
describ
human
coronavirus
previous
shown
product
infect
human
monocytesmacrophag
wherea
poorli
infect
cell
studi
examin
whether
sarscov
could
product
infect
purifi
monocytesmacrophag
pm
deriv
human
donor
cell
unlik
cell
produc
viral
titer
tcid
ml
sarscov
replic
poorli
pm
produc
titer
tcid
ml
find
similar
result
report
cell
titer
rang
tcid
ml
interest
sarscov
protein
detect
pm
produc
signific
amount
interferon
ifn
one
case
preliminari
electron
microscop
studi
demonstr
sarscovlik
particl
could
enter
cell
possibl
via
phagocytosi
result
suggest
sarscov
like
human
cov
poorli
infect
human
pm
product
cell
limit
infect
given
import
monocytesmacrophag
immun
respons
possibl
infect
sarscov
alter
infect
may
import
cours
infect
human
publish
elsevi
bv
sarscoronaviru
sarscov
discov
associ
case
sever
acut
respiratori
syndrom
sar
newli
identifi
member
divers
group
larg
envelop
positivestrand
rna
virus
order
nidoviral
famili
coronavirida
holm
berger
et
al
number
coronavirus
describ
includ
human
coronavirus
number
anim
coronavirus
mous
hepat
viru
stadler
et
al
holm
structur
protein
sarscov
includ
larg
type
memcel
virion
bud
upon
membran
endoplasm
reticulum
migrat
cell
surfac
within
cisterna
endoplasm
reticulum
extrud
extracellular
space
ng
et
al
b
goldsmith
et
al
extracellular
viru
particl
seen
accumul
larg
quantiti
along
plasma
membran
infect
cell
ng
et
al
goldsmith
et
al
sarscov
appear
highli
suscept
type
interferon
ifn
studi
reveal
cinatl
et
al
hensley
et
al
spiegel
et
al
et
al
well
known
produc
monocytesmacrophag
particip
induc
resist
viral
replic
cytokin
activ
cellular
gene
destroy
viral
mrna
inhibit
translat
protein
addit
induc
major
histocompat
complex
class
protein
express
infect
cell
increas
level
protein
present
cell
abil
uninfect
cell
resist
kill
natur
killer
cell
goodbourn
et
al
previou
studi
monocytesmacrophag
infect
human
cov
collin
macrophag
express
human
peptidas
n
yeager
et
al
identifi
receptor
receptor
still
unknown
collin
studi
collin
show
effici
infect
monocyt
induc
apoptosi
determin
dna
chang
annexin
v
stain
poorli
infect
cell
apoptosi
correl
differenti
releas
infecti
viru
therefor
determin
whether
monocytemacrophag
donor
cell
could
infect
sarscov
examin
abil
produc
infecti
viru
sinc
previous
shown
measl
viru
induc
product
purifi
monocytemacrophag
pm
cultur
yilla
et
al
also
ask
whether
similar
cultur
produc
respons
sarscov
infect
sarscov
urbani
strain
use
infect
pm
deriv
healthi
adult
donor
result
studi
suggest
sarscov
infect
pm
cultur
yield
littl
product
viru
might
curb
sarscov
infect
cell
blood
healthi
adult
donor
label
ah
collect
heparin
tube
peripher
blood
mononuclear
cell
pbmc
isol
buffi
coat
gener
lymphocyt
separ
medium
icncappel
cell
collect
process
describ
previous
yilla
et
al
monocyt
isol
use
microbead
mitenyi
biotec
accord
manufactur
protocol
puriti
assess
flow
cytometri
hlaa
b
c
hladr
viabil
trypan
blue
exclus
donor
cell
could
use
everi
experi
number
limit
minim
interdonor
variabl
pbmc
obtain
bulk
frozen
use
replic
experi
vero
cell
gift
anthoni
sanchez
center
diseas
control
prevent
cdc
atlanta
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
life
technolog
supplement
fetal
bovin
serum
methionin
specif
radioact
cimmol
obtain
icn
fetal
calf
serum
penicillinstreptomycin
methioninefre
medium
invitrogen
life
technolog
human
convalesc
serum
hc
use
protein
detect
obtain
sarscovposit
patient
see
ksiazek
et
al
day
infect
antispik
anti
monoclon
antibodi
mab
gift
ralph
tripp
cdc
atlanta
use
experi
neutral
sarscov
antibodi
use
identifi
sarscov
protein
infect
pm
vero
cell
sarscov
urbani
strain
isol
sarsinfect
patient
describ
ksiazek
et
al
rota
et
al
propag
vero
cell
titer
urbani
sarscov
determin
vero
monolay
tissu
cultureinfect
dose
tcid
ml
brief
tcid
determin
ad
serial
dilut
viru
vero
monolay
plate
well
inspect
daili
virusinduc
cytopath
effect
four
day
infect
supernat
remov
cell
wash
twice
pb
stain
ml
crystal
violet
solut
h
stain
cell
wash
twice
pb
allow
air
dri
titer
subsequ
record
log
tcid
unit
use
karber
method
gray
pm
plate
plate
corn
inc
infect
tcid
sarscov
vero
supernat
contain
volum
l
h
c
serumfre
medium
rock
cell
subsequ
cultur
presenc
serum
h
fig
control
cell
mockinfect
uninfect
vero
cell
supernat
equival
cell
number
approxim
h
infect
monocyt
display
characterist
typic
macrophag
indirect
elisa
react
isotyp
use
quantit
level
experiment
sampl
human
pbl
biomed
lab
use
assay
standard
estim
concentr
ifn
induc
experi
cytokin
control
experi
sampl
ad
antiifn
antibodyco
microtit
well
pbl
biomed
lab
assay
accord
manufactur
protocol
one
unit
equival
pg
antibodi
neutral
experi
pm
treat
min
prior
infect
neutral
uml
antibodi
chemicon
intern
pm
cultur
h
infect
analyz
presenc
sarscov
protein
test
infecti
viru
produc
donor
h
innoculum
wash
h
cell
reincub
h
fresh
medium
contain
antibodi
prior
process
sar
antigen
vero
cell
starv
ml
methioninefre
dmem
min
c
prior
label
mciml
methionin
incorpor
label
termin
addit
mm
cold
methionin
h
cell
collect
centrifug
lyse
min
lysi
buffer
sd
nadoc
mm
nacl
mm
trishcl
ph
mm
edta
contain
mm
pmsf
pefablock
boehring
mannheim
immunoprecipit
total
lysat
preced
preclear
cell
lysat
normal
mous
serum
immun
complex
remov
adsorpt
protein
gsepharos
bead
preclear
lysat
immunoprecipit
differ
antisera
parallel
fig
immun
complex
adsorb
protein
gsepharos
bead
collect
centrifug
immun
complex
wash
prepar
sdspolyacrylamid
gel
electrophoresi
previous
describ
burk
et
al
brief
pm
wash
pb
contain
bovin
serum
albumin
sodium
azid
fac
buffer
resuspend
fac
buffer
contain
appropri
dilut
antibodi
cell
stain
sar
protein
use
either
hc
gift
tom
ksiazek
cdc
anti
mab
gift
ralph
tripp
cdc
antihlaa
b
c
locu
product
clone
bd
bioscienc
pharmingen
antihladr
clone
bd
bioscienc
pharmingen
clone
beckman
coulter
clone
bear
beckman
coulter
clone
beckman
coulter
use
detect
presenc
absenc
respect
protein
pm
surfac
cell
surfacestain
antibodi
min
c
wash
fac
buffer
fix
paraformaldehyd
min
c
cell
permeabil
fac
buffer
contain
saponin
permeabil
buffer
min
room
temperatur
test
intracellular
presenc
sar
protein
intern
stain
sarscov
carri
min
room
temperatur
either
hc
anti
mab
indic
figur
legend
fig
reactiv
antibodi
detect
indirect
stain
use
either
goat
antimous
goat
antihuman
secondari
antibodi
conjug
alexafluor
molecular
probe
inc
stain
cell
analyz
fourcolor
flow
cytometri
beckman
coulter
epicsxl
beckman
coulter
adc
softwar
side
scatter
versu
forward
scatter
paramet
use
gate
fig
vero
monolay
either
mock
infect
vero
supernat
infect
tcid
sarscov
cell
radiolabel
methionin
h
cell
harvest
lyse
describ
section
subsequ
clarifi
cell
lysat
immunoprecipit
anti
mab
human
convalesc
serum
human
conv
serum
immun
complex
collect
adsorpt
protein
gsepharos
bead
protein
identifi
follow
separ
sdspage
gel
cell
size
side
scatter
versu
hladr
marker
monocyt
macrophag
use
analyz
monocytemacrophag
cell
popul
quadrant
analysi
use
fluorescein
isothiocyan
versu
phycoerythrintexa
red
use
differenti
infect
cell
uninfect
cell
mean
fluoresc
intens
measur
gener
plot
display
graph
figur
cell
prepar
electron
microscopi
accord
publish
protocol
brief
pm
infect
sarscov
h
fix
buffer
glutaraldehyd
specimen
process
embed
epoxi
resin
section
examin
pm
presenc
sarscov
protein
follow
infect
sarscov
mock
infect
vero
supernat
timecours
experi
h
carri
order
determin
whether
sarscov
could
replic
pm
fig
protein
detect
use
hc
recogn
sarscov
kda
n
kda
protein
methioninelabel
infect
vero
cell
fig
radiolabel
cystein
requir
reveal
addit
sarscov
protein
unpublish
observ
peak
protein
level
detect
pm
h
infect
fig
show
result
titrat
done
cell
two
donor
sinc
highest
amount
protein
detect
follow
addit
tcid
viru
subsequ
experi
carri
concentr
h
higher
inoculum
viru
vero
cell
supernat
toxic
cell
result
fewer
infect
cell
fig
experi
level
background
stain
usual
low
shown
fig
next
test
pm
nine
donor
ai
fig
use
hc
cell
four
nine
donor
posit
sarscov
protein
detect
intern
cell
permeabil
reactiv
serum
detect
cell
surfac
data
shown
anti
mab
becam
avail
use
test
mockinfect
sarscovinfect
pm
four
donor
b
h
sar
protein
fig
inset
mab
react
singl
kda
protein
sarscovinfect
vero
cell
fig
found
donor
pm
reactiv
hc
also
reactiv
mab
protein
similarli
absenc
protein
pm
infect
donor
h
consist
absenc
sarscov
protein
could
detect
hc
thu
infect
pm
sarscov
success
pm
studi
test
donor
c
f
diaz
et
al
posit
sarscov
protein
neg
sarscov
product
infecti
viru
low
viru
titer
tcid
ml
obtain
donor
f
infecti
viru
secret
infect
pm
donor
c
impli
despit
detect
sarscov
protein
hightit
viru
secret
infect
pm
pm
shown
releas
ifn
viral
infect
yilla
et
al
therefor
ask
whether
sarscov
also
induc
pm
supernat
sarscovinfect
pm
mockinfect
pm
test
product
h
infect
tabl
cell
three
nine
donor
studi
donor
h
signific
level
uml
measur
follow
sarscov
infect
furthermor
sarscov
protein
detect
donor
pm
remain
six
donor
bg
absent
low
level
uml
detect
follow
infect
sarscov
protein
could
observ
cell
four
six
donor
tabl
examin
age
race
sex
donor
determin
whether
paramet
influenc
respons
sarscov
tabl
due
small
number
donor
unabl
convincingli
show
factor
influenc
result
obtain
despit
secret
low
level
sarscov
protein
fail
detect
donor
g
unabl
identifi
reason
variat
pattern
seen
donor
suggest
multipl
factor
may
affect
abil
donor
cell
support
sarscov
infect
sinc
sarscov
infect
specifi
presenc
protein
associ
low
level
absenc
look
effect
antibodi
sarscov
infect
treat
cell
two
donor
h
antibodi
analyz
sarscov
protein
express
cell
fig
addit
antibodi
led
detect
sarscov
protein
previous
neg
donor
cell
percentag
posit
cell
higher
donor
donor
h
possibl
donor
cell
produc
lower
level
ifn
ie
level
could
easili
neutral
addit
fail
improv
detect
protein
data
shown
furthermor
presenc
antibodi
infect
cell
produc
low
level
infecti
viru
tcid
ml
electron
microscopi
use
character
sarscov
infect
cell
donor
b
produc
follow
infect
cluster
viruslik
particl
could
seen
engulf
pseudopodlik
extens
macrophag
prepar
entri
cell
possibl
phagocytosi
fig
within
cytoplasm
sarscov
virion
seen
aggreg
enlarg
membranebound
structur
presum
phagolysosom
fig
although
phagocyt
natur
structur
yet
confirm
none
morpholog
featur
indic
viral
replic
detect
pm
cultur
donor
b
includ
nascent
viral
particl
form
cytoplasm
membran
doublemembran
vesicl
propos
replic
complex
coronavirus
adher
virion
cell
surfac
studi
examin
whether
human
monocytesmacrophag
support
sarscov
replic
particip
progress
sar
diseas
found
evid
viru
entri
limit
replic
minim
product
infecti
viru
viral
titer
monocytemacrophag
cultur
inocul
sarscov
exceed
tcid
ml
titer
excess
seen
vero
cell
electron
microscop
studi
suggest
sarscov
might
enter
pm
phagocytosi
rather
adhes
cell
surfac
membran
fusion
seen
permiss
cell
examin
would
necessari
determin
actual
mode
viral
entri
monocyt
macrophag
dendrit
cell
also
recent
shown
take
sarscov
yang
et
al
pm
viru
detect
phagolysosom
cell
surfac
viru
associ
cell
membran
fusion
flow
cytometr
studi
sarscovinfect
cell
detect
protein
cell
surfac
thu
suggest
pm
may
lack
specif
receptor
sar
entri
electron
microscop
studi
suggest
differ
replic
process
pm
permiss
vero
cell
replic
center
seen
sarscovinfect
vero
cell
absent
infect
pm
examin
significantli
sarscov
infect
pm
appear
inhibit
presenc
sarscov
antigen
detect
pm
produc
signific
level
uml
howev
detect
pm
produc
uml
pm
four
six
donor
cell
produc
signific
level
antibodi
ad
cultur
system
taken
togeth
data
suggest
human
monocytesmacrophag
support
lowlevel
product
infect
sarscov
level
infect
modifi
coronavirus
previous
shown
infect
monocytemacrophag
cultur
differ
outcom
collin
infect
monocyt
well
induc
apoptosi
releas
higher
titer
infecti
viru
cultur
media
contrast
infect
monocyt
poorli
fail
induc
increas
apoptosi
releas
low
amount
infecti
viru
collin
studi
sarscovinfect
pm
suggest
like
sarscov
also
infect
monocytesmacrophag
poorli
virus
may
lack
viabl
receptor
entri
monocyt
pbmc
sar
patient
also
examin
evid
infect
replic
sarscov
li
et
al
report
minusstrand
rna
copi
sarscov
genom
observ
pbmc
use
indic
replic
viru
howev
intermedi
long
last
could
detect
day
infect
li
et
al
sensit
sarscov
shown
monkey
monkey
cell
line
exampl
treatment
vero
cell
ifn
result
inhibit
sarscov
replic
cinatl
et
al
hensley
et
al
spiegel
et
al
et
al
express
sarscov
protein
type
pneumocyt
infect
macaqu
also
sever
reduc
prophylact
treatment
sarscovinfect
monkey
haagman
et
al
reduct
viral
replic
excret
protein
express
pneumocyt
pulmonari
damag
note
infect
macaqu
treat
compar
infect
macaqu
treat
haagman
et
al
result
show
sarscov
infect
monocytesmacrophag
modul
consist
find
role
sarscov
infect
monocytesmacrophag
play
cours
diseas
human
yet
determin
role
could
import
would
otherwis
indic
low
level
product
infect
given
import
cell
guid
immun
respons
infect
antigen
present
cytokin
product
data
suggest
differ
level
product
infect
may
occur
indic
infect
monocytesmacrophag
differ
could
contribut
diseas
cours
exampl
coinfect
paramyxoviru
human
metapneumoviru
note
sarsinfect
patient
infect
hypothes
render
person
suscept
sarscov
diseas
stephenson
although
human
metapneumoviru
infect
describ
previous
interf
ifnmedi
antivir
respons
paramyxovirus
shown
interfer
respons
gotoh
et
al
bossert
et
al
thu
possibl
interfer
could
facilit
sarscov
infect
anoth
exampl
variabl
product
could
explain
differ
diseas
outcom
associ
increas
sever
diseas
increas
age
young
children
appear
least
suscept
elderli
suscept
seriou
complic
infect
known
level
highest
young
decreas
age
katschinski
et
al
shodel
siegal
perhap
ageassoci
variat
product
may
help
explain
ageassoci
differ
sarscov
diseas
yang
colleagu
recent
demonstr
myeloid
dendrit
cell
interact
sarscov
protein
bind
viru
yang
et
al
although
dendrit
cell
could
infect
sarscov
author
suggest
could
serv
vehicl
dissemin
viru
potenti
monocytesmacrophag
dendrit
cell
take
sarscov
may
relev
sar
pathogenesi
vivo
